Since Ellman International was founded in 1959, the company has grown to become a global leader in advanced radiofrequency (RF) technology for precision surgical and aesthetic procedures. Today, Ellman serves the aesthetic, multi-specialty surgical, dental and veterinary markets.
The company’s reputation for providing high quality, reliable products including the legacy Surgitron line of RF surgical generators and the newer Pellevé Wrinkle Reduction System positions Ellman for further expansion in the aesthetic and surgical markets.
Our advanced radiofrequency (RF) products are used around the world for precision surgical and aesthetic procedures.
Executing on a strategy for growth, Ellman recently enriched its product portfolio by adding laser and IPL systems. With the acquisition of Sandstone Medical Technologies, Ellman now offers a full complement of aesthetic products that also includes the Pellevé Wrinkle Reduction System and the Surgitron Surgical RF Systems. The company is now uniquely positioned to further penetrate the aesthetic market by offering a full complement of value based products that address the customer’s needs yet are affordable.
With a foundation based on excellence in advanced RF technology, a strong research and development program and established worldwide sales channels, Ellman’s commitment to sustained growth will result in long term success.
The company’s reputation for providing high quality, reliable products including the legacy Surgitron line of RF surgical generators and the newer Pellevé Wrinkle Reduction System positions Ellman for further expansion in the aesthetic and surgical markets.
Our advanced radiofrequency (RF) products are used around the world for precision surgical and aesthetic procedures.
Executing on a strategy for growth, Ellman recently enriched its product portfolio by adding laser and IPL systems. With the acquisition of Sandstone Medical Technologies, Ellman now offers a full complement of aesthetic products that also includes the Pellevé Wrinkle Reduction System and the Surgitron Surgical RF Systems. The company is now uniquely positioned to further penetrate the aesthetic market by offering a full complement of value based products that address the customer’s needs yet are affordable.
With a foundation based on excellence in advanced RF technology, a strong research and development program and established worldwide sales channels, Ellman’s commitment to sustained growth will result in long term success.
Employees: 11-50
Founded date: 1959
Investors 1
| Date | Name | Website |
| 17.07.2021 | Baird Capi... | bairdcapit... |
Mentions in press and media 2
| Date | Title | Description |
| 02.01.2014 | Biopharma company raises $21.5M to treat inflammatory skin disorders | LXR agonists have generated interest as a source of life science innovation with the potential to treat conditions such as atherosclerosis and Alzheimer’s disease. Dr. Neal Walker is a dermatologist and serial entrepreneur who will serve as... |
| - | Biopharma company raises $21.5M to treat inflammatory skin disorders | A biopharma management company has created a new business that will use liver X receptor agonists to take on dermatological disorders. NeXeption has raised $21.5 million in a Series A financing round to form Alexar Therapeutics, according t... |